Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Practice pays $4.75M to resolve fraud allegations | Insulin pods recalled | Takeaways from CRT 2026 | Dyslipidemia guidelines

News You Need to Know Today
Practice pays $4.75M to resolve fraud allegations | Insulin pods recalled | Takeaways from CRT 2026 | Dyslipidemia guidelines
Monday, March 16, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiology practice, cardiologists pay $4.75M to resolve DOJ fraud allegations

The physicians allegedly performed medically unnecessary ablation procedures as part of a years-long fraud scheme.

READ MORE >
Department of Justice DOJ
Share on Twitter Share on Facebook Share on Linkedin

Cardiology practice, cardiologists pay $4.75M to resolve DOJ fraud allegations

Share on Twitter Share on Facebook Share on Linkedin
Department of Justice DOJ
The physicians allegedly performed medically unnecessary ablation procedures as part of a years-long fraud scheme.
READ MORE >

FDA announces recall of insulin delivery pods

Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.

READ MORE >
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of insulin delivery pods

Share on Twitter Share on Facebook Share on Linkedin
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.
READ MORE >

CRT 2026: Key takeaways for interventional cardiologists

CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.

READ MORE >
Several interventional cardiology late-breaking studies were presented at the Cardiovascular Research Technologies (CRT) 2026 meeting March 7-10, and experts from the Society of Society highlighted what they felt was most impactful to clinical practice. Photo by Dave Fornell.
Share on Twitter Share on Facebook Share on Linkedin

CRT 2026: Key takeaways for interventional cardiologists

Share on Twitter Share on Facebook Share on Linkedin
Several interventional cardiology late-breaking studies were presented at the Cardiovascular Research Technologies (CRT) 2026 meeting March 7-10, and experts from the Society of Society highlighted what they felt was most impactful to clinical practice. Photo by Dave Fornell.
CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.
READ MORE >

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations. 

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations. 
READ MORE >

Featured Articles

Prior authorization may reduce access to important heart failure drugs

Researchers noted that these requirements are more common for Black and Hispanic patients, creating a critical barrier to guideline-recommended care.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Prior authorization may reduce access to important heart failure drugs

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
Researchers noted that these requirements are more common for Black and Hispanic patients, creating a critical barrier to guideline-recommended care.
READ MORE >

AI is transforming patient care—and cardiologists have a critical role to play

While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.

READ MORE >
The Society for Cardiovascular Angiography and Interventions (SCAI) is urging federal policymakers to ensure physicians play a central role in guiding the integration of artificial intelligence (AI) into clinical care, while also raising questions about liability as the technology expands across healthcare.
Share on Twitter Share on Facebook Share on Linkedin

AI is transforming patient care—and cardiologists have a critical role to play

Share on Twitter Share on Facebook Share on Linkedin
The Society for Cardiovascular Angiography and Interventions (SCAI) is urging federal policymakers to ensure physicians play a central role in guiding the integration of artificial intelligence (AI) into clinical care, while also raising questions about liability as the technology expands across healthcare.
While the Trump administration is pushing to accelerate clinical AI adoption, SCAI has emphasized that physicians must guide how the technology is implemented and governed.
READ MORE >

Apixaban bests rivaroxaban in new DOAC comparison

The randomized COBRRA trial included more than 2,700 patients with acute symptomatic pulmonary embolism or proximal deep-vein thrombosis. 

READ MORE >
Blood leg clotting thrombosis ultrasound
Share on Twitter Share on Facebook Share on Linkedin

Apixaban bests rivaroxaban in new DOAC comparison

Share on Twitter Share on Facebook Share on Linkedin
Blood leg clotting thrombosis ultrasound
The randomized COBRRA trial included more than 2,700 patients with acute symptomatic pulmonary embolism or proximal deep-vein thrombosis. 
READ MORE >

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data

The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature. 

READ MORE >
Selection of stent images captured with the MicroAngioscope from Vena Medical. Images courtesy of Kan et al. and Stroke.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears intravascular device billed as ‘world’s smallest camera’ as physicians share new data

Share on Twitter Share on Facebook Share on Linkedin
Selection of stent images captured with the MicroAngioscope from Vena Medical. Images courtesy of Kan et al. and Stroke.
The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature. 
READ MORE >

In Case You Missed It

Gore completes acquisition of medtech company behind next-gen heart device

Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.

READ MORE >
Conformal Medical CLAAS
Share on Twitter Share on Facebook Share on Linkedin

Gore completes acquisition of medtech company behind next-gen heart device

Share on Twitter Share on Facebook Share on Linkedin
Conformal Medical CLAAS
Gore has officially acquired Conformal Medical, the company known for an investigational LAAO device that uses a proprietary foam implant. The transaction was first announced in January.
READ MORE >

Heart failure company BioVentrix files for IPO

The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.

READ MORE >
BioVentrix's Revivent system
Share on Twitter Share on Facebook Share on Linkedin

Heart failure company BioVentrix files for IPO

Share on Twitter Share on Facebook Share on Linkedin
BioVentrix's Revivent system
The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.
READ MORE >

Medtronic’s RDN system receives new reimbursement approval

More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s RDN system receives new reimbursement approval

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
More than 40 million adults now have improved access to Medtronic's Symplicity Spyral renal denervation technology.
READ MORE >

In Other News

FDA merges all adverse event reporting systems into new AEMS platform

Adverse event reports for food, drugs, vaccines, dietary supplements and medical devices will soon be available in one place. The U.S. Food and Drug Administration said the change will simplify reporting for consumers and allow it to react in real-time to FOIA requests.

READ MORE >
U.S. FDA Sign
Share on Twitter Share on Facebook Share on Linkedin

FDA merges all adverse event reporting systems into new AEMS platform

Share on Twitter Share on Facebook Share on Linkedin
U.S. FDA Sign
Adverse event reports for food, drugs, vaccines, dietary supplements and medical devices will soon be available in one place. The U.S. Food and Drug Administration said the change will simplify reporting for consumers and allow it to react in real-time to FOIA requests.
READ MORE >

Data breach on care management company impacts 5K patients at NYC Health

Many of the details are unknown, as an investigation is ongoing. The National Association on Drug Abuse Programs said it became aware of an invasion of its network in January 2026. The nonprofit supports 35,000 people—mainly Medicaid enrollees—in the state of New York. 

READ MORE >
NYC Health + Hospitals/Metropolitan
Share on Twitter Share on Facebook Share on Linkedin

Data breach on care management company impacts 5K patients at NYC Health

Share on Twitter Share on Facebook Share on Linkedin
NYC Health + Hospitals/Metropolitan
Many of the details are unknown, as an investigation is ongoing. The National Association on Drug Abuse Programs said it became aware of an invasion of its network in January 2026. The nonprofit supports 35,000 people—mainly Medicaid enrollees—in the state of New York. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Cardiology practice pays $3.5M in data breach settlement | Key ACC trials | More screening, treatment needed for CKD
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart
Hospital sues cardiology practice | Cardiologist fired for speaking out, lawsuit claims | FDA approves another GLP-1 pill
Week in Review: ‘Practice-changing’ cardiology research | Another Impella recall | FDA clears AI for pulmonary hypertension
Innovations at ACC 2026 | Lower drug costs increase medication compliance | TAVR temporary pacing lead cleared by FDA
March's Top Stories: 40 Under 40 | Court affirms death sentence for Texas nurse | Recreational Adderall use | TAVR innovation
Key takeaways from ACC.26 | FDA confirms recall for heart pumps | AI alerts deliver value | Practice adds in-house smart lab

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …9
    • Page 10
    • Page 11
    • Page 12
    • Current page 13
    • Page 14
    • Page 15
    • Page 16
    • Page 17 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup